Objective: The preoperative ejection fraction (EF) and left ventricular (LV) end-systolic dimension are known predictors of postoperative LV dysfunction after mitral valve repair. We investigated the effect of a preoperative history of atrial fibrillation and moderate pulmonary hypertension (defined as pulmonary artery systolic pressure >50 mm Hg) on early postoperative LV dysfunction.
Conclusions: In addition to the established predictors of postoperative LV dysfunction, the presence of preoperative pulmonary hypertension and a history of atrial fibrillation in patients undergoing mitral valve repair surgery increased the risk of early postoperative LV dysfunction by almost twofold. (J Thorac Cardiovasc Surg 2014;148:422-7)
Mitral valve repair is the recommended treatment for patients with severe degenerative mitral valve disease. Despite having a preoperative preserved ejection fraction (EF), a number of patients will develop early left ventricular (LV) dysfunction after valve reconstruction. A number of studies have examined the echocardiographic predictors of LV dysfunction after valve replacement. 1 However, some have examined this question in a mixed cohort of valve repair and valve replacement, 2, 3 and others have examined a mixed cohort of mitral valve disease (degenerative, ischemic, and rheumatic). 4 None have thoroughly examined the nonechocardiographic predictors of early postoperative LV dysfunction. Furthermore, whether early postoperative LV dysfunction after mitral valve reconstruction affects morbidity and mortality has not been examined.
In the present large series, we sought to examine the echocardiographic and nonechocardiographic predictors of early postoperative LV dysfunction after mitral valve repair for degenerative valve disease and its effects on surgical outcomes.
METHODS

Study Population
From June 2003 to December 2010, we retrospectively analyzed the data from 646 consecutive patients who underwent mitral valve surgery for degenerative mitral valve regurgitation by a single surgical team. Patients were excluded from the present study if they had undergone mitral valve replacement (1 patient) or had not undergone a complete predischarge echocardiogram (13 patients). Patients with concomitant tricuspid valve repair or coronary artery bypass grafting for incidental coronary disease found during preoperative catheterization were included in the present study. After the exclusions, 632 patients were included in the present analysis.
The Mount Sinai School of Medicine institutional review board approved the present research protocol.
The patients underwent a variety of techniques in repairing the mitral valve using a lesion-specific approach, as described previously. 5, 6 These techniques included quadrangular or triangular resection, leaflet sliding plasty, neochordal replacement, and commissuroplasty. Most patients received a complete annuloplasty ring; a small percentage received an incomplete annuloplasty ring. Tricuspid valve repair was undertaken if more than mild regurgitation or annular dilatation was present. Complete left sided or biatrial ablation was undertaken for all patients in persistent or permanent atrial fibrillation (AF).
During valve repair, myocardial protection was maintained using an induction dose of antegrade blood cardioplegia, with maintenance cardioplegia given mostly in a retrograde manner by way of a catheter in the coronary sinus. Cold blood cardioplegia was administered at 4 C and consisted of a 4:1 ratio of blood to cardioplegia. The doses were administered approximately every 20 to 25 minutes. Before removal of the crossclamp, a dose of warm blood was administered through the retrograde catheter.
Echocardiographic Parameters
All patients had a preoperative transthoracic echocardiogram documenting severe mitral valve regurgitation. The degree of regurgitation was measured using a variety of techniques according to the guidelines of the American Society of Echocardiography. If doubt was present regarding the degree of mitral valve regurgitation on an echocardiogram from an outside institution, the echocardiogram was repeated at our hospital using proximal isovelocity surface area (effective regurgitant orifice area, effective regurgitant volume) and qualitative measurements such as reversal of flow in the pulmonary veins to assess mitral regurgitation. Transthoracic echocardiograms were performed in all patients after valve repair and before discharge from the hospital. The mean interval to echocardiography was 4.1 days. Postoperative LV dysfunction was defined as an LVEF<50%. Other echocardiographic parameters such as the LV end-systolic diameter (LVESD), LV end-diastolic diameter (LVEDD), and left atrial diameter were also measured using the American Society of Echocardiography guidelines. Preoperative pulmonary artery systolic pressures were obtained from preoperative catheterization if available and, if not, by echocardiography using the simplified Bernoulli's equation [pulmonary artery systolic pressure ¼ 4 3 (peak tricuspid regurgitant velocity) 2 þ mean right atrial pressure]. Pulmonary hypertension (PHT) was defined using the American Heart Association/American College of Cardiology guideline of 50 mm Hg. AF was defined as permanent, persistent, and paroxysmal AF. All patients with permanent or persistent AF underwent ablation. All but 1 patient with paroxysmal AF underwent ablation. That patient had a history of 1 brief episode of paroxysmal AF and did not undergo ablation.
Statistical Analysis
Continuous variables are presented as the mean AE standard deviation, if normally distributed, and the median and interquartile range, if not normally distributed. Categorical variables are presented as proportions and absolute numbers. For continuous variables, the normality test was performed using the combination of the Kolmogorov-Smirnov test and a visual assessment of the histograms. The differences between the 2 groups were detected using the chi-square test or Fisher's exact test for categorical variables and unpaired and paired Student t tests or the Mann-Whitney U test for continuous variables. Logistic and linear regression analyses were performed to identify the univariate and multivariate predictors of postoperative LV dysfunction and LVEF, respectively. Variables with P < .25 on univariate analysis were included in the final multivariate model. In logistic regression analysis, the model fit and predictive power were validated using the Hosmer-Lemeshow goodness-of-fit test and c-statistic. Before multivariate analysis, a correlation analysis between each variable was performed (Pearson or Spearman, as appropriate) to ensure no violation of the assumption of multicollinearity (cutoff correlation coefficient < 0.7). The results are presented as odds ratios, with the corresponding 95% confidence intervals. P<.05 was considered statistically significant. All P values are the results of 2-tailed tests. The statistical analysis was performed using IBM SPSS Statistics for Windows, version 20.0 (SPSS, Inc, IBM Corp, Armonk, NY).
RESULTS
The baseline characteristics of the patients are listed in Table 1 . Of the 646 patients, 242 (38.3%) developed postoperative LV dysfunction. We observed that 68% of the patients in the series had a preoperative LVEF > 60% and 85.3% of patients had a preoperative LVEF > 50%. On average, the patients who developed LV dysfunction were 2.7 years older. More than one half of the patients (57.9%) in the series were symptomatic. The preoperative comorbidities were otherwise similar in both groups. The mean preoperative LVEF was slightly lower in the patients who developed postoperative LV dysfunction compared with those who did not (59.3% vs 61.5%). The patients who developed postoperative LV dysfunction were more likely to have a dilated ventricle, PHT, and AF. The etiology of the degenerative disease was not different, and the repair techniques used were similar in both groups (Table 2 ). Barlow's disease was evident in 339 patients (53.6%), and posterior leaflet prolapse was the most common lesion noted (475 patients; 75.2%). Tricuspid annuloplasty was undertaken in 413 patients (65.3%).
The mean cardiopulmonary bypass times and crossclamp times were not significantly different between the 2 groups ( Table 2) . Figure 1 illustrates the preoperative and postoperative cardiac chamber sizes in the entire series. The mean postoperative LVEF changed in the entire cohort by a mean of À7.3% AE 10.8%. After valve repair, a significant decrease was seen in the LVESD, LVEDD, and left atrial diameter. Tables 3 and 4 list the independent predictors of postoperative LV dysfunction after mitral valve repair, including LVESD, preoperative AF, and preoperative PHT. The preoperative LVEF showed a trend toward predicting postoperative LV dysfunction but the difference was not statistically significant. We observed that in patients with a preoperative LVEF of <60%, 34.2%
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The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 2 423 developed postoperative LV dysfunction. When the preoperative LVEF was <60%, the LVESD was >40 mm, and AF and PHT were present, the incidence of postoperative LV dysfunction increased to 66.7% (Table 5) . We examined the mortality and morbidity between the 2 groups (Table 6 ). One patient in the entire series died (0.2%) but that patient had not developed postoperative LV dysfunction. When comparing major postoperative morbidity, we found no significant differences between the 2 groups. The incidence of major morbidity and/or mortality was 5.7%. Respiratory failure, defined as mechanical ventilation for >48 hours (for any reason), occurred in 4% of patients without LV dysfunction and 3.6% of patients with LV dysfunction (P ¼ .549). The cause in most of these cases was related to postoperative right ventricular dysfunction in those with longer crossclamp times, and the patients required inotropic support for the right ventricle.
DISCUSSION
Postoperative LV dysfunction after mitral valve surgery has been shown to occur in a number of studies. 2, 7 Similar to these series, the incidence of postoperative LV dysfunction after mitral valve repair in our series was significant, despite 85.3% of our patients having a preoperative LVEF of >50%. Understanding the predictive factors provides insight into the postoperative treatment of patients with degenerative mitral valve disease. In our study, the LVESD and the presence of PHT and AF independently predicted postoperative LV dysfunction (LVEF < 50%). In a series of 861 patients, Suri and colleagues 2 examined the predictors of LV dysfunction after mitral valve surgery and also found that increased LV size, worsening heart failure symptoms, preoperative LVEF, and AF predicted postoperative LV dysfunction. Their series consisted of a mixed population of patients undergoing either valve repair or replacement. Tribouilloy and colleagues 7 examined the predictors of LV dysfunction at 10.8 months after mitral valve repair. At 10 months after surgery, they continued to find a decrease in the mean LVEF of 9%. The largest incidence of postoperative LV dysfunction (33%) was found in those patients with a preoperative LVEF < 64% and LVESD ! 37 mm. Our study is unique in that it examined early postoperative LV dysfunction (mean, 4.1 days) in patients who had only undergone mitral valve repair for degenerative disease.
Our study did not find that the preoperative LVEF predicted postoperative LV dysfunction, in contrast to previous published studies. On multivariate analysis, the P value for this measurement was .057. Although it showed a trend toward significance, the preoperative LVEFs were very similar in both groups and, hence, led to a type 1 error in our study, because we did not have a sufficient sample size to elicit a difference between the 2 groups.
We observed an overall decrease in the LVEF of 7.2% postoperatively. A number of explanations exist for this decrease in the postoperative LVEF. Starling and colleagues 8 illustrated that the LVEF in the presence of mitral regurgitation is overestimated as a result of the increased ventricular preload (end-diastolic volume). After valve repair, this excess preload is removed, leading to a decrease in the end-diastolic volume and, subsequently, a decrease in the LVEF. They showed that the contractile reserve is a better indicator of LV function in the presence of severe mitral regurgitation. Their work has been supported by more recent evidence that measurements other than the LVEF, such global strain and speckle tracking, can better assess ventricular function when severe mitral regurgitation is present. 9, 10 Other arguments for the early decrease in the LVEF could be the increased afterload in the ventricle after valve repair and the stress and/or myocardial injury that occurs after aortic crossclamping. A recent study found a similar decrease in the LVEF, in addition to global longitudinal and circumferential strain, on early postoperative echocardiograms at 7 days. 11 Our finding that preoperative PHT increased the incidence of postoperative LV dysfunction was likely a result of the severity and duration of mitral regurgitation. Enriquez-Sarano and colleagues 12 elegantly reported that as the severity of mitral regurgitation increased, a corresponding increase occurred in the pulmonary artery pressures. PHT also increased the incidence of right ventricular dysfunction and could subsequently lead to a decrease in LV preload and LVEF. In a recent multicenter registry, patients with PHT had an increased risk of operative mortality (hazard ratio, 2.15; P ¼ .01) after mitral valve surgery. 13 Furthermore, long-term survival was also diminished in the same study.
Just as with PHT, AF is a marker of the severity of regurgitation and portends a worse prognosis in patients with severe mitral regurgitation.
14 AF has also been shown to predict late survival after mitral valve repair. 15 The greatest incidence of postoperative LV dysfunction was seen when patients presented with a combination of LV dysfunction, increased ventricular dimensions, PHT, and AF.
Postoperative LV dysfunction did not affect mortality or morbidity after valve repair. We believe this was because our threshold for defining LV dysfunction was 50%, and most patients who developed LV dysfunction still had a postoperative mean LVEF just <50%. One could postulate that if the threshold definition of LV dysfunction was moved toward 35% to 40%, a greater incidence of postoperative complications would likely be seen, given the potential for a longer intensive care unit and hospital stay; however, this was not examined in our study.
In the present study, the presence of symptoms did not increase the incidence of postoperative LV dysfunction. However, given the finding of a twofold increase in the risk of postoperative dysfunction in patients with preoperative AF or PHT, these results support close follow-up with a low threshold for surgical intervention for patients with severe degenerative mitral valve disease. We also believe that, in expert centers, early surgery in asymptomatic patients should be considered where mortality and morbidity remain low.
The strengths of the present study were the large sample size and a homogenous population of patients with only degenerative mitral valve disease. In addition, all patients in the present series underwent valve repair. The limitations of our study were its retrospective data collection. The preoperative echocardiograms were frequently performed at outside institutions; thus, an operator bias exists in the interpretation of the echocardiograms. Finally, the lasting implications of early postoperative ventricular dysfunction were not examined.
CONCLUSIONS
Early postoperative LV dysfunction occurs commonly after mitral valve repair for degenerative disease. The independent predictors of postoperative LV dysfunction were a large LV chamber size, PHT, and AF. Although no increase in perioperative mortality or morbidity was observed, patients who present with preoperative AF or PHT had a twofold increase risk of developing postoperative LV dysfunction. Data presented as n (%). LV, Left ventricular.
